期刊文献+

高效液相色谱法测定草酸艾司西酞普兰片的含量 被引量:4

Determination of Escitalopram Oxalate Tablets by HPLC
暂未订购
导出
摘要 目的采用高效液相色谱法测定草酸艾司西酞普兰片的含量。方法色谱柱为C18柱(250 mm×4.6 mm,5μm),流动相为磷酸盐缓冲液-甲醇(51∶49),检测波长为238 nm。结果艾司西酞普兰质量浓度在25~150μg/mL范围内与峰面积呈良好线性关系(r=0.999 9),平均回收率为99.60%,RSD为0.44%。结论该方法简便,专属性及重现性好,可用于测定草酸艾司西酞普兰片的含量。 Objective To establish a HPLC method for the assay of Escitalopram Oxalate Tablets.Methods The HPLC method was used with C18 column(250 mm×4.6 mm,5 μm).The mobile phase was phosphoric acid buffer solution-methanol(51 ∶49),with the detection wavelength at 238 nm.Results The linear range of escitalopram was 25-150 μg/mL(r=0.999 9).The average recovery rate was 99.60%,RSD=0.44%. Conclusion This method is convenient with good specificity and good reproducibility for the assay of Escitalopram Oxalate Tablets.
出处 《中国药业》 CAS 2011年第16期32-33,共2页 China Pharmaceuticals
关键词 草酸艾司西酞普兰片 含量测定 高效液相色谱法 Escitalopram Oxalate Tablets content determination HPLC
  • 相关文献

参考文献1

二级参考文献14

  • 1Owens MJ,Knight DL,Nemeroff CB.Second generation SSRIs:human monoamine transporter binding profile of escitalopram and R-fluoxetine[J].Biol Psychiatry,2001,50:345-350.
  • 2Chen FH,Larsen MB,Sanchezc,et al.The S-enantiomer of R,S-citalopram,increases inhibitor binding to the human serotonin transporter by an allosteric mechanism.Comparison with other serotonin transporter inhibitors[J].Eur Neuropsychopharmacology,2005,15:193-198.
  • 3Mork A,Kreilgaard M,Sanchez C.The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats[J].Neuropharmacology,2003,45:167-173.
  • 4Sanchez C.R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalization model[J].Eur J Pharmacol,2003,464:155-158.
  • 5Sanchez C,Gruca P,Papp M.R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model of depression[J].Behav Pharmacol,2003,14:465-470.
  • 6Plenge P,Mellerup ET,Laursen H.Affinity modulation of[^3H]imipramine,[^3H]paroxetine and[^3H]citalopram binding to the 5-HT transporter from brain and platelets[J].Eur J Pharmacol,1991,206:243-250.
  • 7Fava M,Davidson KG.Definition and epidemiology of treatment resistant depression[J].Psychiatr Clin North Am,1996,19:179-200.
  • 8Thase ME.The Concept of Remission:validity and limitations[J].JClin Psychiatry,2006,67:478-481.
  • 9Thase ME.Evaluating antidepressant therapies:Remission as the optimal outcome[J].J Clin Psychiatry,2003,64(Suppl 13):18-25.
  • 10Murdoch D,Keam SJ.Escitalopram:a review of its use in the management of major depressive disorder[J].Drugs,2005,65:2379-2404.

共引文献125

同被引文献13

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部